CVE-2014-9352
Cross-site scripting (XSS) vulnerability in the mail administration login panel in Scalix Web...
Cross-site scripting (XSS) vulnerability in the mail administration login panel in Scalix Web Access 11.4.6.12377 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in the mail administration login panel in Scalix Web Access 11.4.6.12377 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors.
- Record
CVE-2014-9352- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in the mail administration login panel in Scalix Web Access 11.4.6.12377 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors.
- Record
CVE-2014-9352- Updated
- 2026-11-02
EUVDEUVD-2014-9177 No score
Cross-site scripting (XSS) vulnerability in the mail administration login panel in Scalix Web Access 11.4.6.12377 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors.
- Record
EUVD-2014-9177- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-whf2-4g7v-9wcm No score
Cross-site scripting (XSS) vulnerability in the mail administration login panel in Scalix Web...
Cross-site scripting (XSS) vulnerability in the mail administration login panel in Scalix Web Access 11.4.6.12377 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors.
- Record
GHSA-whf2-4g7v-9wcm- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2014-9352 is a medium vulnerability (CVSS 4.3) in Scalix Web Access, published December 9, 2014. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.15%, the 66th percentile. No source names a fixed version.